FR2427331A2 - HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES - Google Patents

HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES

Info

Publication number
FR2427331A2
FR2427331A2 FR7913823A FR7913823A FR2427331A2 FR 2427331 A2 FR2427331 A2 FR 2427331A2 FR 7913823 A FR7913823 A FR 7913823A FR 7913823 A FR7913823 A FR 7913823A FR 2427331 A2 FR2427331 A2 FR 2427331A2
Authority
FR
France
Prior art keywords
substances
products containing
medicinal products
hydantoin derivatives
hydantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913823A
Other languages
French (fr)
Other versions
FR2427331B2 (en
Inventor
Albert Gordon Caldwell
Norman Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2427331A2 publication Critical patent/FR2427331A2/en
Application granted granted Critical
Publication of FR2427331B2 publication Critical patent/FR2427331B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Abstract

Nouveaux dérivés de l'hydantoïne. Ils sont caractérisés par la formule :New derivatives of hydantoin. They are characterized by the formula:

FR7913823A 1978-05-31 1979-05-30 HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES Granted FR2427331A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25575/78A GB1599740A (en) 1978-05-31 1978-05-31 Hydantoin derivatives

Publications (2)

Publication Number Publication Date
FR2427331A2 true FR2427331A2 (en) 1979-12-28
FR2427331B2 FR2427331B2 (en) 1983-01-28

Family

ID=10229898

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913823A Granted FR2427331A2 (en) 1978-05-31 1979-05-30 HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES

Country Status (11)

Country Link
JP (1) JPS554371A (en)
AU (1) AU4762579A (en)
BE (1) BE876670R (en)
DE (1) DE2922070A1 (en)
FR (1) FR2427331A2 (en)
GB (1) GB1599740A (en)
IL (1) IL57436A0 (en)
IT (1) IT1164693B (en)
NL (1) NL7904311A (en)
SE (1) SE7904700L (en)
ZA (1) ZA787354B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014076A2 (en) * 1979-01-18 1980-08-06 Beecham Group Plc Hydantoin derivatives, their preparation and pharmaceutical compositions
CN1084792C (en) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 High air-temperature high furnace space gas preheating method

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019223A1 (en) * 1979-05-09 1980-11-26 The Wellcome Foundation Limited Optically active hydantoin derivatives, their synthesis, pharmaceutical formulations containing them, and intermediates
EP0023083A1 (en) * 1979-06-27 1981-01-28 Beecham Group Plc Oxodiazole derivatives, processes for their production and pharmaceutical composition containing them
US4908456A (en) * 1989-04-05 1990-03-13 Takatori Corporation Process for preparing methylolated hydantoins

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362839A1 (en) * 1976-06-03 1978-03-24 Wellcome Found HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES
EP0001238A1 (en) * 1977-09-05 1979-04-04 The Wellcome Foundation Limited Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362839A1 (en) * 1976-06-03 1978-03-24 Wellcome Found HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES
EP0001238A1 (en) * 1977-09-05 1979-04-04 The Wellcome Foundation Limited Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014076A2 (en) * 1979-01-18 1980-08-06 Beecham Group Plc Hydantoin derivatives, their preparation and pharmaceutical compositions
EP0014076A3 (en) * 1979-01-18 1980-09-17 Beecham Group Limited Hydantoin derivatives, their preparation and pharmaceutical compositions
CN1084792C (en) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 High air-temperature high furnace space gas preheating method

Also Published As

Publication number Publication date
DE2922070A1 (en) 1979-12-06
IT1164693B (en) 1987-04-15
SE7904700L (en) 1979-12-01
FR2427331B2 (en) 1983-01-28
IL57436A0 (en) 1979-09-30
GB1599740A (en) 1981-10-07
NL7904311A (en) 1979-12-04
JPS554371A (en) 1980-01-12
AU4762579A (en) 1979-11-22
ZA787354B (en) 1980-08-27
BE876670R (en) 1979-11-30
IT7949253A0 (en) 1979-05-30

Similar Documents

Publication Publication Date Title
FR2416012A1 (en) DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
FR2392971A1 (en) PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCT CONTAINING SUCH SUBSTANCES
FR2416234A1 (en) METRONIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING
FR2367053A1 (en) NEW PHENOXY-AMINO-PROPANOL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2390420A1 (en) NEW CYCLOPEPTIDIC DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2400512A1 (en) NEW NITRO-IMIDAZOLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2422643A1 (en) NEW DERIVATIVES OF IMIDAZOLIDINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2433512A1 (en) INDANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SAME
FR2361901A1 (en) NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
BE887970A (en) NOVEL OYTOCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES
FR2434154A1 (en) NOVEL IMIDAZOLE DERIVATIVES, ESPECIALLY USEFUL AS ANTICONVULSANTS, AND THEIR PREPARATION PROCESS
FR2360601A1 (en) NEW DERIVATIVES OF PHOSPHONEOUS ACIDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2363330A1 (en) MEDICINE INTENDED TO REDUCE FERTILITY IN MAMMALS
FR2370744A1 (en) NEW AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
FR2377419A1 (en) NEW 11B-SUBSTITUTES 1,3,5 (10) TRIENIC STEROID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICINAL PRODUCT
FR2415103A1 (en) ACIDS AND DERIVATIVES OF 4-PYRIDONE-3-CARBOXYLIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2355021A1 (en) NEW DERIVATIVES OF IMIDAZOTHIAZINE AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2415636A1 (en) NEW GUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2427331A2 (en) HYDANTOIN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES
FR2361361A1 (en) NEW DERIVATIVES OF CYCLOPENTANE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
FR2355830A1 (en) NEW DERIVATIVES OF 6-7-BENZOMORPHANE, THEIR OBTAINING AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2370745A1 (en) NEW DERIVATIVES OF MORPHANTHRIDINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
OA04707A (en) New derivatives of urea and hydantoin and regulatory compositions for plant growth.
FR2356643A1 (en) 5-0-ACYL-IMIDAZOLE-4-CARBOXAMIDES, THEIR OBTAINING AND PHARMACEUTICAL COMPOSITION IN CONTAINER
FR2355012A1 (en) NEW DERIVATIVES OF DIHYDRO- AND TETRAHYDRO-IMINOTHIAZINE, AND THEIR APPLICATION AS MEDICINAL PRODUCTS